Publications
Specialty
Search
Psych Congress Network
09/13/2024
The United States Food and Drug Administration (FDA) has granted clearance for DaylightRx, a prescription digital therapeutic designed to treat generalized anxiety disorder (GAD).
Oncology
09/13/2024
Inhye Ahn, MD, shares insight into non-covalent BTK inhibitor pirtobrutinib treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have received at least 2 prior lines of therapy.
First Report Managed Care
09/13/2024
The US Department of Health and Human Services (HHS) has announced updates to Medicare payments and policies to improve healthcare accessibility, equity, and quality for millions of Americans, according to a press release by the HHS.
First Report Managed Care
09/13/2024
In this interview, a leading expert discusses myeloproliferative neoplasms, as presented at the SOHO annual conference. Explore the interview to gain key insights into interferon therapies and important considerations for payers regarding coverage decisions.
Oncology
09/13/2024
On September 12th, 2024, the US FDA approved subcutaneous coformulation of atezolizumab plus hyaluronidase for adult patients with non-small cell lung cancer, small cell lung cancer, hepatocellular carcinoma, melanoma, and alveolar soft part sarcoma.
Rheumatology & Arthritis
09/13/2024
A novel magnetic resonance imaging categorization system improved interpretation consistency between clinicians and radiologists, possibly enhancing the accuracy of clinical decision-making.
Advances in Inflammatory Bowel Disease Network
09/12/2024
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
APP Institute Dermatology
09/12/2024
Explore an AI imaging app pilot study with Dr Roxana Daneshjou,.
Journal of Clinical Pathways
09/12/2024
Learn about different implementation strategies for patient navigation presented at a session at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange.
Foot and Ankle Surgery Institute, Podiatry, Podiatry Today
09/12/2024
A poster presented at the AOFAS Annual Meeting compared the complication rates of staples, screws, and plates in patients undergoing midfoot arthrodesis.
Oncology
09/12/2024
Jonathan Kaufman, MD, discusses recent updates for treating patients with relapsed/refractory multiple myeloma with new and immune cellular therapies.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/12/2024
“Our results show that the use of OCT guidance improves clinical outcomes and enhances safety and effectiveness of coronary stenting, reducing cardiac death, MI, stent thrombosis, and the need for revascularisation by 38% in a group of very complex patients, which more reflects contemporary interventional cardiology practice,” said Professor Byeong-Keuk Kim.
Oncology, Journal of Clinical Pathways
09/12/2024
Steve Narod, MD, discusses the incidence of endometrial cancer among people who are BRCA mutation carriers.
Foot and Ankle Surgery Institute, Podiatry, Podiatry Today
09/12/2024
Can research-savvy surgeons distinguish between abstract with human authors versus AI? This poster dives into the topic.
Foot and Ankle Surgery Institute, Podiatry Today
09/12/2024
How might diabetes impact MIS hallux valgus intervention?
Cath Lab Digest, CardioVascular, Journal of Invasive Cardiology
09/12/2024
Strikingly, patients who received the drug-coated balloon were almost 90% more likely to experience a cardiovascular event after 2 years compared to those receiving standard treatment with drug-eluting stents.
EMSWorld
09/12/2024
A 34-person strike team from the Clark County Fire Department and three other local fire departments in Southern Nevada is being deployed to Washoe County to assist with efforts to fight the Davis Fire near Reno.
EP Lab Digest
09/12/2024
iRhythm Technologies Press Release
EP Lab Digest
09/12/2024
Elutia Inc., a pioneer in drug-eluting biomatrix products, today announced a landmark achievement with the first-ever patient implant of EluPro, the world’s first antibiotic-eluting biologic envelope cleared by the U.S. Food and Drug Administration.
Oncology
09/12/2024
At the 2024 SOHO meeting, John Mascarenhas, MD, shares highlights from a discussion on the utilization and selection of optimal JAK inhibitor therapies for the treatment of patients with myelofibrosis.
Reimbursement Library From A to Z
Subscribe and never miss an article!
Today's Wound Clinic Newsletter
